Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics ...

Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Results from the separate SCALP study, involving 102 patients with moderate-to-severe scalp psoriasis, showed a significantly higher proportion of patients receiving Cosentyx had 90% plaque ...

That's where a salicylic acid shampoo comes in. Like a dandruff shampoo, these formulas can help relieve dryness, flakes, and ...

Accropeutics’ therapy met the primary endpoint and key secondary endpoints in a Phase II trial. Image credit: Vysotskaya Kristina / Shutterstock. Accropeutics’ oral, selective TYK2/JAK1 inhibitor ...